(Q51769139)

11 April 2018

title

Recombinant LipL32 and LigA from Leptospira are unable to stimulate protective immunity against leptospirosis in the hamster model. (English)

1 reference

11 April 2018

1 reference

Deanna S Deveson Lucas

1

1 reference

11 April 2018

Paul A Cullen

2

1 reference

11 April 2018

Miranda Lo

3

1 reference

11 April 2018

Amporn Srikram

4

1 reference

11 April 2018

Rasana W Sermswan

5

1 reference

11 April 2018

Ben Adler

6

1 reference

11 April 2018

language of work or name

English

0 references

publication date

9 March 2011

1 reference

11 April 2018

published in

Vaccine

1 reference

11 April 2018

volume

29

1 reference

11 April 2018

issue

18

1 reference

11 April 2018

page(s)

3413-3418

1 reference

11 April 2018

Opsonic monoclonal antibodies against lipopolysaccharide antigens of Leptospira interrogans serovar hardjo

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Comparison of three different leptospiral vaccines for induction of a type 1 immune response to Leptospira borgpetersenii serovar Hardjo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Surfaceome of Leptospira spp.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Leptospiral proteins recognized during the humoral immune response to leptospirosis in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Leptospira and leptospirosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

LipL32 is an extracellular matrix-interacting protein of Leptospira spp. and Pseudoalteromonas tunicata

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

In LipL32, the major leptospiral lipoprotein, the C terminus is the primary immunogenic domain and mediates interaction with collagen IV and plasma fibronectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Calcium Binds to LipL32, a Lipoprotein from Pathogenic Leptospira, and Modulates Fibronectin Binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Major surface protein LipL32 is not required for either acute or chronic infection with Leptospira interrogans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Epitope mapping of pathogenic Leptospira LipL32.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Pathogenic Leptospira species express surface-exposed proteins belonging to the bacterial immunoglobulin superfamily

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Osmolarity, a key environmental signal controlling expression of leptospiral proteins LigA and LigB and the extracellular release of LigA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Physiological osmotic induction of Leptospira interrogans adhesion: LigA and LigB bind extracellular matrix proteins and fibrinogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Leptospiral immunoglobulin-like proteins elicit protective immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Vaccine adjuvants: current state and future trends

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Genome-wide transposon mutagenesis in pathogenic Leptospira species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Hamster model of leptospirosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Cross-protective immunity against leptospirosis elicited by a live, attenuated lipopolysaccharide mutant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.084

10.1016/J.VACCINE.2011.02.084

7 January 2021

Identifiers

DOI

1 reference

11 April 2018

1 reference

11 April 2018